TG Therapeutics Inc. (TGTX)
NASDAQ: TGTX
· Real-Time Price · USD
27.91
0.18 (0.65%)
At close: Aug 19, 2025, 3:59 PM
27.92
0.04%
After-hours: Aug 19, 2025, 06:38 PM EDT
TG Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 5.06M | 23.33M | 3.88M | 6.88M | -10.71M | -14.42M | 113.93M | -47.61M | -39.23M | -52.99M | -35.82M | -40.51M | -69.01M | -93.34M | -85.64M | -78.5M | -90.63M |
Depreciation & Amortization | 56K | 62K | 64K | 72K | 82K | 91K | 126K | 85K | 121K | 126K | 129K | 131K | 129K | 133K | 129K | 120K | 112K |
Stock-Based Compensation | 14.97M | 11.95M | 11.77M | 9.48M | 9.34M | 9.38M | 9.18M | 12.54M | 6.82M | 11.05M | 6.99M | -975K | 2.12M | 14.36M | 14M | 16.3M | 16.62M |
Other Working Capital | 58.7M | -22.46M | 2.83M | 1.56M | 4.53M | 6.66M | 6.71M | -38K | -2.63M | 17.01M | 20.02M | -9.23M | -3.4M | -8.75M | 4.02M | 1.37M | -38K |
Other Non-Cash Items | -262K | -242K | 3.9M | -231K | 19.25M | 24.06M | -14.62M | 1.34M | 710K | 937K | 1.53M | 654K | 989K | 597K | 610K | 539K | 652K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -24.28M | 15.19M | -186K | n/a | n/a | n/a | n/a | n/a | 96K | 139K | 155K | 127K |
Change in Working Capital | -48.54M | -60.74M | -31.82M | -10.66M | -6.07M | -8.05M | -40.11M | -8.18M | -28.32M | 17.01M | -7.33M | -8.42M | -2.92M | -8.75M | 3.56M | 1.21M | -8.24M |
Operating Cash Flow | -28.71M | -25.64M | -12.21M | 5.54M | -8.21M | -13.21M | 83.7M | -42.01M | -59.9M | -23.87M | -34.49M | -49.12M | -68.69M | -86.91M | -67.2M | -60.17M | -81.36M |
Capital Expenditures | -25K | -21K | -24K | n/a | n/a | n/a | n/a | n/a | n/a | -3K | -4K | n/a | -7K | -80K | -79K | -175K | -67K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.99M | n/a | 43.67M | n/a | n/a | n/a | 514K |
Purchase of Investments | -93.31M | -57.89M | -101.61M | -69.73M | -82.66M | -68.43M | -56.28M | n/a | -22.17M | -4M | -31.47M | -14.92M | -56.89M | -12.23M | -11.8M | -14.05M | -17.45M |
Sales Maturities Of Investments | 80.4M | 73.7M | 92.3M | 71.5M | 73.4M | 23.68M | 26.05M | 30.5M | 16M | 20.27M | 28.48M | 25.3M | 13.22M | 15.6M | 11.25M | 11.75M | 17M |
Other Investing Acitivies | n/a | n/a | -24K | 1.76M | -9.26M | -44.76M | -30.23M | 30.5M | -6.17M | n/a | -2.99M | 10.38M | -43.67M | 3.37M | -552K | -2.3M | -514K |
Investing Cash Flow | -12.93M | 15.79M | -9.33M | 1.76M | -9.26M | -44.76M | -30.23M | 30.5M | -6.17M | 16.27M | -2.99M | 10.38M | -43.67M | 3.29M | -631K | -2.48M | -514K |
Debt Repayment | n/a | n/a | 137.26M | n/a | n/a | n/a | n/a | n/a | 25M | n/a | n/a | n/a | -975K | 54.59M | -7.39M | -7.2M | n/a |
Common Stock Repurchased | -6.12M | -6.61M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 21K | 539K | -659K | n/a | 10K | n/a | 420K | 47.05M | 238K | 49K | 275K | 135K | 125K | -812K | 29K | 38K | -55K |
Financial Cash Flow | -6.1M | -6.07M | 134.45M | 135K | 10K | -1K | 421K | 47.05M | 25.24M | 49K | 275K | 135K | -850K | 56M | -7.36M | -7.16M | -55K |
Net Cash Flow | -47.75M | -15.93M | 114.21M | 7.43M | -17.46M | -57.97M | 53.9M | 35.54M | -40.83M | -7.55M | -37.21M | -38.6M | -113.21M | -27.62M | -75.19M | -69.81M | -81.92M |
Free Cash Flow | -28.74M | -25.66M | -12.23M | 5.54M | -8.21M | -13.21M | 83.7M | -42.01M | -59.9M | -23.87M | -34.5M | -49.12M | -68.7M | -86.99M | -67.28M | -60.34M | -81.42M |